SCHEMBL4952989

SCHEMBL4952989

CCCC(=O)OC(CCSCC)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39
ALDH1A1 P00352 1/20 0.36
LMNA P02545 3/20 0.34
METAP2 P50579 4/20 0.33
METAP1 P53582 2/20 0.33
PPARG P37231 2/20 0.33
PPARA Q07869 2/20 0.33
ACE P12821 1/20 0.33
CHRM1 P11229 1/20 0.31
AKR1A1 P14550 1/20 0.31
CHRM3 P20309 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
ADRA1A P35348 1/20 0.31
HRH1 P35367 1/20 0.31
DRD3 P35462 1/20 0.31
SLC6A3 Q01959 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC2 Q92769 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4953320 0.90 ALDH1A1 (0.36) ALDH1A1LMNAACECHRM1AKR1A1
SCHEMBL4957014 0.87 LMNA (0.38) TSHRALDH1A1LMNABHMTMAPT
SCHEMBL4951805 0.86 TSHR (0.37) TSHRMETAP2METAP1PPARGPPARA
SCHEMBL4953978 0.85 TSHR (0.36) TSHRMETAP2METAP1PPARGPPARA
SCHEMBL4952847 0.85 RNPEP (0.43) ALDH1A1LMNAACECHRM1AKR1A1
SCHEMBL4956971 0.83 ALDH1A1 (0.39) TSHRALDH1A1LMNAACEHDAC1
SCHEMBL4953747 0.81 TSHR (0.38) TSHRMETAP2METAP1PPARGPPARA
SCHEMBL28380784 0.79 LMNA (0.44) TSHRALDH1A1LMNAPPARGTDP1
SCHEMBL4955374 0.78 ALDH1A1 (0.38) ALDH1A1LMNAMETAP2METAP1ACE
SCHEMBL4951966 0.78 BHMT (0.34) PPARGPPARACHRM1AKR1A1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465471-B2 Palatability of aquaculture feed NOVUS INTERNATIONAL, INC. (US) 2008-12-16 US disclosed
WO-2007147155-A1 POLYOL ESTER COMPOUNDS NOVUS INTERNATIONAL INC. (US) 2007-12-21 WO disclosed
US-20070292485-A1 POLYOL ESTER COMPOUNDS NOVUS INTERNATIONAL INC. (US) 2007-12-20 US disclosed
US-20050215623-A1 Palatability of aquaculture feed NOVUS INTERNATIONAL, INC. (US) 2005-09-29 US disclosed
EP-1531672-A2 ANTIMICROBIAL COMPOSITIONS Novus International, Inc. (US) 2005-05-25 EP disclosed
US-20040175434-A1 Antimicrobial compositions NOVUS INTERNATIONAL, INC. 2004-09-09 US disclosed
WO-2004019683-A2 ANTIMICROBIAL COMPOSITIONS NOVUS INTERNATIONAL, INC. (US) 2004-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070292485-A1 POLYOL ESTER COMPOUNDS PNLIP, ELOVL1, ELOVL5 TSHR 4149/4885ALDH1A1 679/4885LMNA 1572/4885
US-20050215623-A1 Palatability of aquaculture feed TAS2R3, TAS2R1, TAS2R20 TSHR 1282/4885ALDH1A1 585/4885LMNA 4474/4885
US-20040175434-A1 Antimicrobial compositions MRPL21, FPR1, ARG1 TSHR 4028/4885ALDH1A1 2079/4885LMNA 2272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.